首页> 美国卫生研究院文献>Carcinogenesis >Insulin-like growth factor-binding protein-3 promotes transforming growth factor-β1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells
【2h】

Insulin-like growth factor-binding protein-3 promotes transforming growth factor-β1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells

机译:胰岛素样生长因子结合蛋白3促进转化的食管细胞中转化生长因子-β1介导的上皮向间充质转化和运动

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Insulin-like growth factor-binding protein (IGFBP)-3 is overexpressed frequently in esophageal squamous cell carcinoma. Yet, the role of IGFBP3 in esophageal tumor biology remains to be elucidated. We find that IGFBP3 facilitates transforming growth factor (TGF)-β1-mediated epithelial-to-mesenchymal transition (EMT) in transformed human esophageal epithelial cells, EPC2–hTERT–EGFR–p53R175H. In organotypic 3D culture, a form of human tissue engineering, laser-capture microdissection revealed concurrent upregulation of TGF-β target genes, IGFBP3 and EMT-related genes in the cells invading into the stromal compartment. IGFBP3 enhanced TGF-β1-mediated EMT as well as transcription factors essential in EMT by allowing persistent SMAD2 and SMAD3 phosphorylation. TGF-β1-mediated EMT and cell invasion were enhanced by ectopically expressed IGFBP3 and suppressed by RNA interference directed against IGFBP3. The IGFBP3 knockdown effect was rescued by IGFBP3I56G/L80G/L81G, a mutant IGFBP3 lacking an insulin-like growth factor (IGF)-binding capacity. Thus, IGFBP3 can regulate TGF-β1-mediated EMT and cell invasion in an IGF or insulin-like growth factor 1 receptor-independent manner. IGFBP3I56G/L80G/L81G also promoted EMT in vivo in a Ras-transformed human esophageal cell line T-TeRas upon xenograft transplantation in nude mice. In aggregate, IGFBP3 may have a novel IGF-binding independent biological function in regulation of TGF-β1-mediated EMT and cell invasion.
机译:胰岛素样生长因子结合蛋白(IGFBP)-3在食管鳞状细胞癌中经常过表达。然而,IGFBP3在食管肿瘤生物学中的作用仍有待阐明。我们发现,IGFBP3在转化的人食管上皮细胞EPC2–hTERT–EGFR–p53 R175H 中促进了转化生长因子(TGF)-β1介导的上皮-间质转化(EMT)。在器官型3D培养中,一种人类组织工程学形式-激光捕获显微切割术揭示了侵入间质区的细胞中TGF-β靶基因,IGFBP3和EMT相关基因同时上调。 IGFBP3通过允许持续的SMAD2和SMAD3磷酸化增强TGF-β1介导的EMT以及EMT中必需的转录因子。异位表达的IGFBP3增强了TGF-β1介导的EMT和细胞侵袭,并被针对IGFBP3的RNA干扰抑制。 IGFBP3的敲低效应可以通过IGFBP3 I56G / L80G / L81G 来挽救,IGFBP3 I56G / L80G / L81G 是一种缺乏胰岛素样生长因子(IGF)结合能力的突变IGFBP3。因此,IGFBP3可以以IGF或胰岛素样生长因子1受体独立的方式调节TGF-β1介导的EMT和细胞侵袭。在裸鼠异种移植后,IGFBP3 I56G / L80G / L81G 还在Ras转化的人食道细胞系T-TeRas中体内促进了EMT。总体而言,IGFBP3在调节TGF-β1介导的EMT和细胞侵袭中可能具有新颖的IGF结合独立生物学功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号